Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3531779)

Published in J Biol Chem on November 07, 2012

Authors

Brent A Wilkerson1, G Daniel Grass, Shane B Wing, W Scott Argraves, Kelley M Argraves

Author Affiliations

1: Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

Articles citing this

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal (2015) 0.94

Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. J Biol Chem (2013) 0.91

Why targeting HDL should work as a therapeutic tool, but has not. J Cardiovasc Pharmacol (2013) 0.90

Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis. Cholesterol (2013) 0.90

S1P control of endothelial integrity. Curr Top Microbiol Immunol (2014) 0.88

Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements. Pflugers Arch (2014) 0.84

Sources, metabolism, and regulation of circulating sphingosine-1-phosphate. J Lipid Res (2015) 0.82

The role of sphingosine-1-phosphate in endothelial barrier function. Biochim Biophys Acta (2014) 0.81

Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. Anal Bioanal Chem (2015) 0.81

HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications. Front Pharmacol (2015) 0.80

Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. J Cell Mol Med (2016) 0.78

Lipids and the endothelium: bidirectional interactions. Curr Atheroscler Rep (2013) 0.78

The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis. Int J Mol Sci (2013) 0.78

AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis. PLoS One (2015) 0.77

Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient. Annu Rev Physiol (2016) 0.77

High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways. Stem Cell Res Ther (2015) 0.76

Anticipatory role of high density lipoprotein and endothelial dysfunction: an overview. Open Biochem J (2014) 0.76

HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms. J Lipid Res (2014) 0.76

High-density lipoprotein: a novel target for antirestenosis therapy. Clin Transl Sci (2014) 0.75

Abluminal stimulation of sphingosine 1-phosphate receptors 1 and 3 promotes and stabilizes endothelial sprout formation. Tissue Eng Part A (2014) 0.75

Resveratrol exerts a biphasic effect on apolipoprotein M. Br J Pharmacol (2015) 0.75

Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia. PLoS One (2017) 0.75

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Lipids Health Dis (2017) 0.75

A Stromal Cell-derived Factor 1 alpha Analogue Improves Endothelial Cell Function in Lipopolysaccharide-induced Acute Respiratory Distress Syndrome. Mol Med (2016) 0.75

A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay. J Lipid Res (2016) 0.75

Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism. PLoS One (2016) 0.75

Articles cited by this

Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08

A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61

Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89

Signaling mechanisms regulating endothelial permeability. Physiol Rev (2006) 7.63

Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol (2005) 6.18

Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (1985) (2001) 5.63

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05

Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods (2006) 4.31

Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem (2007) 3.07

Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton. J Cell Biol (1999) 2.60

Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat Chem Biol (2009) 2.47

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest (2004) 2.36

Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J (2005) 2.29

Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. J Clin Invest (2011) 2.23

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A (2011) 2.18

Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med (2009) 2.12

Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell (1999) 2.02

In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal (2005) 2.01

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J (2000) 2.00

Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol (2007) 1.91

Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J Biol Chem (2006) 1.26

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem (2008) 1.23

Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am J Physiol Cell Physiol (2007) 1.22

Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature. Am J Physiol Heart Circ Physiol (2008) 1.20

N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization. FASEB J (2002) 1.19

Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood (2008) 1.15

Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Atherosclerosis (2011) 1.08

Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung. Acta Pharmacol Sin (2010) 1.06

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis (2011) 1.01

High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol (2003) 0.98

Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules. Am J Physiol Heart Circ Physiol (2010) 0.97

Insulin stabilizes microvascular endothelial barrier function via phosphatidylinositol 3-kinase/Akt-mediated Rac1 activation. Arterioscler Thromb Vasc Biol (2010) 0.91

Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. Biochem Biophys Res Commun (2010) 0.89

Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation. Pediatr Cardiol (2012) 0.85

Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins. Am J Physiol Cell Physiol (2009) 0.85

Down-regulation of S1P1 receptor surface expression by protein kinase C inhibition. J Biol Chem (2009) 0.85

Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3. Am J Physiol Cell Physiol (2008) 0.83

Truncation of the N-terminal ectodomain has implications in the N-glycosylation and transport to the cell surface of Edg-1/S1P1 receptor. J Biochem (2003) 0.80

Articles by these authors

ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell (2009) 2.20

Diverse roles for the LDL receptor family. Trends Endocrinol Metab (2002) 1.99

VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood (2004) 1.81

Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol (1985) (2008) 1.49

Megalin functions as an endocytic sonic hedgehog receptor. J Biol Chem (2002) 1.49

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res (2007) 1.36

Evidence that the satin hair mutant gene Foxq1 is among multiple and functionally diverse regulatory targets for Hoxc13 during hair follicle differentiation. J Biol Chem (2006) 1.34

Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clin Cancer Res (2009) 1.31

Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem (2005) 1.28

Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res (2009) 1.26

Fibulin-1 is required for morphogenesis of neural crest-derived structures. Dev Biol (2008) 1.26

Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn (2007) 1.24

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem (2008) 1.23

Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn (2006) 1.22

Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol (2007) 1.15

ArrayQuest: a web resource for the analysis of DNA microarray data. BMC Bioinformatics (2005) 1.13

Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol (2010) 1.11

Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation. BMC Dev Biol (2006) 1.06

Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem (2004) 1.05

Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells. Atherosclerosis (2008) 1.04

Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci (2003) 1.04

Megalin and the neurodevelopmental biology of sonic hedgehog and retinol. J Cell Sci (2003) 1.03

Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res (2007) 1.02

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis (2011) 1.01

Patterning of embryonic blood vessels. Dev Dyn (2003) 0.99

Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. J Cell Biochem (2004) 0.98

Effects of oxidized and glycated LDL on gene expression in human retinal capillary pericytes. Invest Ophthalmol Vis Sci (2005) 0.96

Megalin and cubilin expression in gallbladder epithelium and regulation by bile acids. J Lipid Res (2004) 0.94

The MUSC DNA Microarray Database. Bioinformatics (2003) 0.94

Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis. Dev Dyn (2010) 0.91

Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol (2009) 0.91

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol (2013) 0.89

A cytokine axis regulates elastin formation and degradation. Matrix Biol (2012) 0.89

Critical role for retinol in the generation/differentiation of angioblasts required for embryonic blood vessel formation. Dev Dyn (2004) 0.89

Effects of modified low-density lipoproteins on human retinal pericyte survival. Ann N Y Acad Sci (2005) 0.89

Differential distribution of cubilin and megalin expression in the mouse embryo. Anat Rec A Discov Mol Cell Evol Biol (2004) 0.89

GeneMesh: a web-based microarray analysis tool for relating differentially expressed genes to MeSH terms. BMC Bioinformatics (2010) 0.87

ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. Biochem Biophys Res Commun (2008) 0.87

CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells. Am J Pathol (2012) 0.87

Fusion of uniluminal vascular spheroids: a model for assembly of blood vessels. Dev Dyn (2010) 0.86

Expression of Patched-1 and Smoothened in testicular meiotic and post-meiotic cells. Microsc Res Tech (2009) 0.86

VEGF directs newly gastrulated mesoderm to the endothelial lineage. Dev Biol (2005) 0.85

VEGF-mediated fusion in the generation of uniluminal vascular spheroids. Dev Dyn (2008) 0.85

Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation. Pediatr Cardiol (2012) 0.85

Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study. Cardiovasc Diabetol (2013) 0.84

Co-expression and interaction of cubilin and megalin in the adult male rat reproductive system. Mol Reprod Dev (2003) 0.84

Cubilin expression is monoallelic and epigenetically augmented via PPARs. BMC Genomics (2013) 0.84

Epithelial trafficking of Sonic hedgehog by megalin. J Histochem Cytochem (2006) 0.82

Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis. World J Biol Chem (2010) 0.82

Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation. BMC Cancer (2011) 0.81

The immune mechanisms of abscopal effect in radiation therapy. Curr Probl Cancer (2015) 0.81

Elevated transferrin saturation, health-related quality of life and telomere length. Biometals (2013) 0.81

Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation. Dev Dyn (2011) 0.80

Serum opacity factor is a streptococcal receptor for the extracellular matrix protein fibulin-1. J Biol Chem (2009) 0.80

Cellularized microcarriers as adhesive building blocks for fabrication of tubular tissue constructs. Ann Biomed Eng (2013) 0.79

Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes. Diabetes Care (2013) 0.78

Helicobacter pylori-induced posttranscriptional regulation of H-K-ATPase α-subunit gene expression by miRNA. Am J Physiol Gastrointest Liver Physiol (2014) 0.78

Telomere length and elevated iron: the influence of phenotype and HFE genotype. Am J Hematol (2013) 0.78

The genetics of vasculogenesis. Novartis Found Symp (2007) 0.77

Aortic valve stenosis and atrial fibrillation influence plasma fibulin-1 levels in patients treated with coronary bypass surgery. Cardiology (2013) 0.77